Dominic Piscitelli Oric Pharmaceuticals, Inc. (ORIC) insider trading activity

Dominic Piscitelli is Chief Financial Officer of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 48,317 shares of ORIC, which is worth approximately $459,977. The most recent transaction as insider was on Jul 01, 2025, when has been sold 20,000 shares (Common Stock) at a price of $10.05 per share, resulting in proceeds of $201,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.3K

54.74% 3M change

42.35% 12M change

Total Value Held $459,977

Dominic Piscitelli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2025	SELL Open market or private sale	$201,000 $10.05 p/Share	20,000 Reduced 29.28%	48,317 Common Stock
Jun 24 2025	SELL Open market or private sale	$340,893 $10.5 p/Share	32,466 Reduced 32.21%	68,317 Common Stock
Jun 23 2025	SELL Open market or private sale	$10,350 $10.01 p/Share	1,034 Reduced 1.02%	100,783 Common Stock
Jun 12 2025	SELL Open market or private sale	$3,000 $10.0 p/Share	300 Reduced 0.29%	101,817 Common Stock
Jun 11 2025	SELL Open market or private sale	$29,789 $10.01 p/Share	2,976 Reduced 2.83%	102,117 Common Stock
Jun 10 2025	SELL Open market or private sale	$3,240 $10.0 p/Share	324 Reduced 0.31%	105,093 Common Stock
Jun 09 2025	SELL Open market or private sale	$3,000 $10.0 p/Share	300 Reduced 0.29%	103,864 Common Stock
Jun 06 2025	SELL Open market or private sale	$26,026 $10.01 p/Share	2,600 Reduced 2.44%	104,164 Common Stock
Dec 16 2024	SELL Open market or private sale	$73,286 $8.28 p/Share	8,851 Reduced 7.66%	106,764 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	24,042 Added 17.22%	115,615 Common Stock
Dec 15 2023	SELL Open market or private sale	$45,319 $8.58 p/Share	5,282 Reduced 5.93%	83,809 Common Stock
Dec 15 2023	SELL Exercise of conversion of derivative security	-	14,042 Reduced 13.62%	89,091 Common Stock
Dec 15 2022	SELL Open market or private sale	$6,789 $3.25 p/Share	2,089 Reduced 3.01%	67,423 Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	-	6,041 Added 8.0%	69,512 Common Stock
Mar 31 2022	BUY Open market or private purchase	$321,600 $5.36 p/Share	60,000 Added 50.0%	60,000 Common Stock

Dominic Piscitelli

Chief Financial Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Value

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC

Account